Filter
996
Text search:
European
Medicines
Agency
Featured
Recommendations
107
New Publications
210
Language
Document type
No document type
417
Studies & Reports
246
Guidelines
165
Manuals
64
Strategic & Response Plan
44
Fact sheets
30
Situation Updates
16
Training Material
9
Resource Platforms
3
Brochures
1
Online Courses
1
Countries / Regions
Western and Central Europe
60
Global
58
Ukraine
38
Eastern Europe
25
Africa
22
Sierra Leone
19
Nigeria
18
Liberia
16
Ghana
16
Kenya
16
Nepal
14
Ethiopia
12
Myanmar / Burma
12
Zambia
11
Syria
10
Latin America and the Carribbean
10
India
9
Germany
9
Eastern Europe and Central Asia
9
Guinea
8
Uganda
8
Philippines
8
Rwanda
8
South Africa
8
Bangladesh
8
Moldova
8
Congo, Democratic Republic of
7
West and Central Africa
7
Zimbabwe
6
Thailand
6
Indonesia
6
Namibia
6
Burkina Faso
5
South Sudan
5
Tanzania
5
Malawi
5
East and Southern Africa
5
South–East Asia Region
5
Russia
5
Senegal
4
Jordan
4
Brazil
4
Hungary
4
Botswana
4
Middle East and North Africa
4
Asia
4
Venezuela
4
Poland
4
Georgia
4
Pakistan
3
Cambodia
3
North Macedonia
3
Yemen
3
Albania
3
Romania
3
Jamaica
3
Morocco
2
Afghanistan
2
Lebanon
2
Mozambique
2
Sudan
2
Argentina
2
Eswatini/ Swaziland
2
Serbia
2
Western Pacific Region
2
Laos
2
Tajikistan
2
Bulgaria
2
Iran
2
Vietnam
2
Côte d’Ivoire / Ivory Coast
1
Saudi Arabia
1
Cameroon
1
Haiti
1
Somalia
1
Iraq
1
Turkey
1
Egypt
1
China
1
Benin
1
Central African Republic
1
Colombia
1
Ecuador
1
Bolivia
1
Greece
1
Lesotho
1
Mexico
1
Sri Lanka
1
Paraguay
1
Bhutan
1
Mongolia
1
Slovakia
1
Kyrgyzstan
1
Australia
1
Gabon
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
259
Clinical Guidelines
114
Public Health
53
Key Resources
48
Women & Child Health
42
Pharmacy & Technologies
23
Capacity Building
8
Toolboxes
AMR
91
COVID-19
89
TB
85
HIV
82
Mental Health
66
Pharmacy
52
Conflict
45
Planetary Health
31
Ebola & Marburg
27
Global Health Education
27
Rapid Response
26
Refugee
23
NTDs
22
Health Financing Toolbox
21
Disability
18
NCDs
18
Malaria
16
Caregiver
14
Natural Hazards
9
Zika
8
2.0 Rapid Response
6
Specific Hazards
5
Polio
4
Cholera
2
Overcoming HIV-related stigma and discrimination in health- care settings and beyond
UNAIDS 2017 | REFERENCE
J Fungi (Basel) . 2019 Aug 16;5(3):75. doi: 10.3390/jof5030075 . Namibia is a sub-Saharan country with one of the highest HIV infection rates in the world. Although care and support services are available that cater for opportunistic infections related to HIV, the main focus is narrow and predominan
...
Preferred product characteristics and clinical development considerations
Access to safe, effective and quality-assured health products and technologies is crucial for achieving universal health coverage and primary health care goals. The continued growth of the aging population; increasing burden of noncommunicable diseases; growing burden of mental health issues; climat
...
Global tuberculosis report 2025
recommended
The WHO Global tuberculosis report 2025 provides a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.
...
This Mpox SPRP Global Monitoring & Evaluation (M&E) Framework, also referred to as the Framework, aims to monitor and report on global progress towards these objectives, including information about country-level response efforts and WHO support to Member States. Regular collection and analysis of da
...
Exciting new treatment approaches make the management of hepatitic C one of the most rapidly developing areas of medicine. The Flying Publisher short Guide to Hepatitis C is an up-to-date source of information for physicians, residents and advanced medical students.
These guidelines present evidence-based recommendations and best practice statements on use of medically important antimicrobials in food-producing animals, based on the WHO list of critically important antimicrobials for human medicine (WHO CIA List). These guidelines aim primarily to help preserve
...
The present guidelines incorporate all these changes, leading to a substantial reconfiguration of therapeutic choices for both disease forms.
HAT is a serious, life-threatening disease and the efficacy of fexinidazole depends on swallowing the medicine after an appropriate intake of food as well as
...
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to
...
16.7.2021
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o
...
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best of our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessi
...
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w
...
Consensual recommendations for outpatient management and home care
and home treatment of patients with COVID-19
